Proton pump inhibitors and gastric acid secretion [23]

American Journal of Gastroenterology

Volumn 96, Issue 12, 2001, Pages 3467-3468

  Wolfe, M Michael ^a,d   Welage, Lynda S ^b   Sachs, George ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROSTAGLANDIN; PROTON PUMP INHIBITOR; SOMATOSTATIN DERIVATIVE; SULFENAMIDE DERIVATIVE;

DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LETTER; PRIORITY JOURNAL; STOMACH ACID SECRETION;

EID: 0035659811     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03924-7     Document Type: Letter

References (8)

1. Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome
2. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs
3. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers
4. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage
5. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients
6. The continuing development of proton pump inhibitors with particular reference to pantoprazole
7. The site of action of pantoprazole in the gastric H+/K+-ATPase
8. Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders